Advanced Search

 

Study ID Status Title Patient Level Data
204981 Recruiting An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD)
204983 Completed An open-label study to evaluate the preference attributes of the ELLIPTA™ dry powder inhaler (DPI) compared to the HandiHaler™ DPI in subjects with Chronic Obstructive Pulmonary Disease (COPD)
204987 Suspended The effects of GSK2586881 on the responses to acute hypoxia and exercise
204990 Completed A Randomized, Open-Label, 8-Week Cross-Over Study to Compare Umeclidinium/Vilanterol with Tiotropium/Olodaterol Once-Daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD)
204999 Terminated Comparative Effectiveness of Belimumab Use among SLE Patients in a Commercially Insured US Population: 2010-2014
205012 Withdrawn A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Sirukumab in Subjects with Polymyalgia Rheumatica
205017 Recruiting A two part, non-randomized, open label study designed to assess the pharmacokinetics of GSK2982772 following administration of modified release formulations in capsule relative to an immediate release reference tablet formulation (Part A) and the pharmacokinetics of escalating, repeat doses of a selected modified release prototype (Part B) in healthy subjects
205021 Not yet recruiting A single-centre, randomized, double-blind (sponsor open), placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2983559, in single (in both fed and fasted states) and repeat oral doses in healthy participants
205024 Completed Skin Acceptability Assessment of 874A in subjects with sensitive skin Under Normal Usage Conditions
205033 Completed A Randomized, Open-Label, Two-Period, Crossover Bioequivalence Study in Healthy Adult Subjects after Single Oral Dosing of a NCH-GSK Acetylcysteine 2% Oral Solution versus a Reference Fluimucil® Acetylcysteine 2% Oral Solution
205034 Completed An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection
205035 Completed A randomized, single-center, crossover, comparative bioavailability and adhesion performance study, comparing single administrations of a new scopolamine transdermal delivery system formulation to the currently established reference transdermal delivery system in healthy adult participants.
205045 Completed A clinical study investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice
205049 Recruiting Prevalence, strain circulation and disease burden of seasonal Influenza A and B in Panama, selected countries of Central America and the Caribbean from the Year 2010 to 2015
205050 Recruiting Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects with Moderate to Severe Atopic Dermatitis
205051 Completed A Study to Investigate the Antimicrobial Activity of two Test Toothpastes in a Plaque Glycolysis and Regrowth Model
205052 Not yet recruiting Drug utilisation study of new users of fluticasone furoate / vilanterol (FF/VI) in the primary care setting: UK Clinical Practice Research Datalink (CPRD) study
205053 Recruiting Study to assess inhaled drug distribution in the distal lung and interstitium using cryobiopsy samples from subjects with suspected Interstitial Lung Disease undergoing cryobiopsy for clinical reasons
205064 Completed PGx7648: Exploratory PGx analysis of ADRB2 Thr164Ile on risk of severe asthma exacerbation in study 201722
205065 Not yet recruiting Evaluation Of Use of Belimumab in Clinical Practice Settings (OBSErve)- Observations from Brazil
205067 Completed A Clinical Study Evaluating the Consumer Perception of an Experimental Mouthwash Formulation After a Single Use
205072 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205076 Withdrawn 205076: A Phase II, multicenter, randomized, double-blind (sponsor-unblind), placebo- controlled, parallel group trial to evaluate the efficacy and safety of sirukumab in subjects with severe, poorly controlled asthma
205081 Recruiting Efficacy, immunogenicity and safety study of GSK Biologicals’ candidate malaria vaccine (SB257049) evaluating various dose schedules in a sporozoite challenge model in healthy malaria-naïve adults
205084 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.